NCT03020251

Brief Summary

This randomized controlled trial will evaluate the effect of a preoperative rehabilitation program at home in patients resected for lung cancer, comparing a control group (C group) receiving only chest physiotherapy and a rehabilitation group (R group) receiving both a training program at home and chest physiotherapy

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
90

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started May 2017

Longer than P75 for not_applicable

Geographic Reach
1 country

6 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 20, 2016

Completed
24 days until next milestone

First Posted

Study publicly available on registry

January 13, 2017

Completed
4 months until next milestone

Study Start

First participant enrolled

May 12, 2017

Completed
8.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 13, 2026

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 13, 2026

Completed
Last Updated

March 13, 2026

Status Verified

March 1, 2026

Enrollment Period

8.8 years

First QC Date

December 20, 2016

Last Update Submit

March 12, 2026

Conditions

Keywords

preoperative rehabilitation programchest physiotherapylung cancer resection

Outcome Measures

Primary Outcomes (1)

  • Hospital length of stay after resection for lung cancer

    the date of discharge will be the real day of discharge from surgery department or the day where the patient will be medically considered as outgoing

    time from the date of the surgery (Day 0) until the date of discharge (Day n) (assessed up to 56 days)

Secondary Outcomes (8)

  • the number of complications

    during the stay in the surgery department or the intensive care unit (up to 56 days)

  • peak oxygen consumption

    evaluation N°1 : during the week before the first date of the intervention (week 1). evaluation N°2: during the week before the date of surgery (week 5)

  • 6 minutes walking distance

    evaluation N°1 : during the week before the first date of the intervention (week 1). evaluation N°2: during the week before the date of surgery (week 5)

  • maximal voluntary quadriceps strength

    evaluation N°1 : during the week before the first date of the intervention (week 1). evaluation N°2: during the week before the date of surgery (week 5)

  • maximal inspiratory and expiratory strength

    evaluation N°1 : during the week before the first date of the intervention (week 1). evaluation N°2: during the week before the date of surgery (week 5)

  • +3 more secondary outcomes

Study Arms (2)

control group (C group)

ACTIVE COMPARATOR

patient will receive preoperative chest physiotherapy (standard supportive care)

Other: preoperative chest physiotherapy

rehabilitation group (R group)

EXPERIMENTAL

patient will receive preoperative chest physiotherapy and a preoperative rehabilitation program at home (exercise training)

Other: preoperative chest physiotherapyOther: preoperative rehabilitation program

Interventions

preoperative chest physiotherapy : 5 sessions per week during 3 weeks

control group (C group)rehabilitation group (R group)

exercise training at home : 5 sessions per week during 3 weeks

rehabilitation group (R group)

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients diagnosed for lung cancer (or highly suspicious for cancer tumor) eligible for resection surgery (lobectomy or pneumonectomy)
  • Age \> 18 years
  • Presence of Chronic Obstructive Pulmonary Disease (COPD) stages 2-4 of Gold (forced expiratory volume (FEV )/ forced vital capacity (FVC) \<70%, FEV \<80% of predicted) and Exertional dyspnea stage MMRC (Medical Research Council) \> 1
  • Patients must provide written consent
  • Member of social security scheme

You may not qualify if:

  • Patients refusing to participate
  • COPD stage 1 Gold (VEMS \>= 80% of the theoretical value)
  • Presenting an operating contraindication during the initial maximal exercise test
  • Presenting cardiac or vascular contraindication to achieve the readaptation program
  • Patient living alone at home
  • Patient with ventilatory assistance at home (oxygen therapy or noninvasive ventilation (NIV))
  • With exercise hypoventilation (PaCO2 \>45 mmHg)
  • Cognitive difficulty
  • unable major
  • pregnancy,
  • patients deprived of liberty by a court or administrative decision

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (6)

CHU Clermont Ferrand, Gabriel Montpied, service de médecine du sport et explorations fonctionnelles,

Clermont-Ferrand, 63000, France

Location

Centre de Recherche en Nutrition Humaine

Clermont-Ferrand, 63009, France

Location

Centre Jean Perrin

Clermont-Ferrand, 63011, France

Location

CHU Grenoble, Hôpital Michallon

Grenoble, 38700, France

Location

Hospices Civiles de Lyon, groupement hospitalier Est, Hopital Louis Pradel

Lyon, 69677, France

Location

CHU Saint-Etienne, CHU Hopital Nord

Saint-Etienne, 42055, France

Location

Related Publications (1)

  • Laurent H, Galvaing G, Thivat E, Coudeyre E, Aubreton S, Richard R, Kwiatkowski F, Costes F, Filaire M. Effect of an intensive 3-week preoperative home rehabilitation programme in patients with chronic obstructive pulmonary disease eligible for lung cancer surgery: a multicentre randomised controlled trial. BMJ Open. 2017 Nov 12;7(11):e017307. doi: 10.1136/bmjopen-2017-017307.

Study Officials

  • Marc FILAIRE, Pr

    Centre Jean Perrin

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 20, 2016

First Posted

January 13, 2017

Study Start

May 12, 2017

Primary Completion

February 13, 2026

Study Completion

February 13, 2026

Last Updated

March 13, 2026

Record last verified: 2026-03

Data Sharing

IPD Sharing
Will not share

Locations